EHC
Encompass Health Corp
123.10$
-0.6%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.3% | +5.6% | -1.1% | +3.8% | +4.0% | +3.6% | +0.2% | +1.4% | +4.5% | +2.7% | +0.7% | – | |
| – | +3.1% | +4.8% | -1.6% | +4.6% | +3.3% | +0.7% | +0.8% | -5.5% | -91.8% | +1,168.4% | -91.9% | – | |
| – | +3.5% | +6.6% | -0.5% | +2.8% | +4.9% | +7.7% | -0.6% | +10.5% | +113.7% | -48.1% | +107.9% | – | |
| – | +6.6% | +20.9% | +0.8% | +5.7% | +1.2% | -2.9% | +10.3% | -24.3% | +1,475.8% | -93.4% | +7.6% | – | |
| – | +4.8% | +404.3% | -3.2% | +6.6% | +1.3% | +2.9% | +1.1% | +22.1% | +166.5% | -61.0% | +180.4% | – | |
| – | +3.3% | -53.3% | +3.9% | -3.0% | +11.1% | +14.9% | -3.0% | -6.0% | +16.3% | +6.4% | -4.4% | – | |
| – | -2.8% | +0.9% | -2.6% | +1.7% | -5.4% | -3.6% | -4.4% | +1.3% | -1.9% | +5.3% | +3.1% | – | |
| – | +13.7% | +8.3% | +4.3% | -1.2% | +9.6% | +18.5% | -0.8% | -7.1% | +17.2% | +12.0% | -9.4% | – | |
| – | +22.8% | +3.0% | +0.0% | -6.0% | +4.4% | +10.6% | +22.6% | -12.0% | +23.4% | +1.8% | -5.0% | – | |
| – | +2.7% | +28.4% | +1.4% | -5.2% | +11.7% | +25.3% | -6.2% | -11.0% | +15.5% | +33.1% | -20.9% | – | |
| – | +5.4% | +9.2% | +3.3% | +1.3% | +5.1% | +11.9% | -0.7% | -4.0% | +12.4% | +9.0% | -5.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.